Skip to main content
HealixMedical Supply

Weight Loss & Metabolism

GLP-1 medications, metabolic health science, obesity medicine, and evidence-based weight management.

6 articles

Clinical obesity medicine GLP-1 semaglutide tirzepatide injection for weight management
Weight Loss & Metabolism7 min

GLP-1 Agonists for Weight Loss: Semaglutide, Tirzepatide, and the Future of Obesity Medicine

Comprehensive clinical review of GLP-1 receptor agonists — SURMOUNT and STEP trial results, mechanism of action, patient selection, monitoring, and what the obesity medicine landscape looks like post-approval.

Jun 28, 2026
Person sleeping with CPAP therapy for sleep apnea treatment
Weight Loss & Metabolism8 min

Zepbound for Obstructive Sleep Apnea: How a Weight Loss Drug Is Transforming OSA Treatment

Tirzepatide (Zepbound) received FDA approval for obstructive sleep apnea in June 2024 — marking the first pharmacological approval for OSA. In 2026, the SURMOUNT-OSA data is reshaping how pulmonologists and sleep specialists approach the condition.

Jun 6, 2026
Medical research laboratory weight loss pharmacology
Weight Loss & Metabolism8 min

Retatrutide: The Triple Agonist That's Producing 24% Weight Loss — The Most Powerful Yet

Retatrutide (Eli Lilly) simultaneously activates GLP-1, GIP, and glucagon receptors — the first triple agonist in clinical development. Phase II data showing 24.2% weight loss at 48 weeks makes it the most potent anti-obesity agent ever tested. Phase III TRIUMPH trial results arrive in late 2026.

May 22, 2026
Clinical pharmacist reviewing GLP-1 medication management and metabolic health protocols
Weight Loss & Metabolism7 min

Ozempic & GLP-1 Weight Loss: What the Clinical Evidence Actually Shows in 2025

Beyond the headlines — evidence-based review of GLP-1 receptor agonists, metabolic benefits, risks, and what healthcare providers need to know about long-term use.

May 18, 2026
Prescription medication and weight management concept
Weight Loss & Metabolism9 min

The GLP-1 Weight Loss Revolution: Ozempic, Wegovy & the Future of Obesity Medicine

GLP-1 receptor agonists have redefined what's possible in weight management. New data shows 20%+ body weight reduction, cardiovascular benefits, and potential applications far beyond obesity.

Jun 5, 2025
Clock surrounded by healthy food representing intermittent fasting concept
Weight Loss & Metabolism7 min

Intermittent Fasting: The Updated Science on Weight, Metabolism & Longevity

New 2024–2025 research clarifies what intermittent fasting actually does to metabolism, insulin sensitivity, and cellular repair — and identifies who benefits most, and who should be cautious.

Mar 12, 2025

Stock Your Facility with Clinical-Grade Supplies

1.5 Million+ FDA-cleared products. Bulk pricing for healthcare facilities nationwide.